Undersea Defence Technology (UDT) 2026: Day Two Highlights
15 April 2026.
UDT 2026 day two: speed, autonomy and AUKUS shape defence
Newsletter
UDT 2026 Day Two Live Update: Maritime and Undersea Risks Intensify
15 April 2026.
UDT 2026 update: maritime conflict reshapes undersea defence priorities
UK Defence: Sovereignty, Scale and the Pressure to Deliver
10 April 2026.
UK defence demand rises; infrastructure protection, AI, undersea capability drive challenges
Air Defence Demand Surges, Outpacing Production Capacity
3 April 2026.
Conflict-driven demand surges expose defence production limits and supply constraints
The Race to Own Alzheimer’s: New Therapies Reshape Market
1 April 2026.
Alzheimer’s shifts to early intervention, with innovation reshaping competitive dynamics.
Global Defence: Drones, Interceptors and Stockpiles
27 March 2026.
Production limits, drone threats, and supply chains reshape defence priorities.
Decentralised Clinical Trials: From Adoption to Execution Risk
25 March 2026.
Decentralised trials shift from adoption to execution as complexity rises
Rheumatoid Arthritis Is Entering a New Competitive Phase
18 March 2026.
RA market shifting beyond biologics, driven by access, innovation, and pricing
The GLP-1 Boom: A Drug Class Redefining the Obesity Market
13 March 2026.
GLP-1 therapies are transforming obesity treatment and reshaping the global pharmaceutical market
How the Middle East Is Exposing Defence Production Limits
6 March 2026.
Middle East missile campaigns expose interceptor shortages and accelerate missile defence production investment.
Precision Payloads: The Rise of Antibody Drug Conjugates in Modern Oncology
4 March 2026.
Antibody drug conjugates are reshaping oncology through precision targeting, expanding pipelines and industry partnerships
Procurement: Sovereignty Is Rewriting the Rules
27 February 2026.
Defence spending rises, but industrial alignment now decides contract winners.
Durability and Delivery: How Biologics Are Redefining Ophthalmology
25 February 2026.
Ophthalmology shifts to durable growth through biologics, delivery innovation and consolidation.
Defence’s New Battleground: Manufacturing Power
20 February 2026.
Manufacturing power now shapes defence procurement, sovereignty and global partnerships.
Industrial Policy & Procurement Realignment
13 February 2026.
US export strategy and UK procurement delays reshape defence competition dynamics
Fill-Finish Manufacturing Is Now a Strategic Constraint
11 February 2026.
Fill-finish capacity now defines biologics launches, valuation strength, and competitive leverage
Why Speed Is Now Deciding Defence Contracts
6 February 2026.
Defence procurement balances rapid modernisation with sustained readiness and industrial resilience
Drug Discovery Outsourcing as Strategy: ROI, Agility, and Advantage
4 February 2026.
Drug discovery outsourcing reshapes pipeline speed, capital efficiency, and competitive advantage
Spending Evolves as Governments Intervene
16 January 2026.
Defence investment shifts toward direct intervention, scalable production and supply-chain resilience
Hybrid Generics & VAMs Accelerate the Innovation Curve
19 November 2025.
Differentiated hybrids and VAMs strengthen competitiveness, extend lifecycles and unlock sustainable growth beyond price competition.
